Showing results (281-290 of 291) with videos related to
Sort By:
Pageof 30
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 8, 2025
Prospective cohort study to validate esophageal dose constraints and predictive models for esophagitis in patients with breast cancer undergoing hypofractionated regional nodal radiotherapyDan-Qiong Wang, Lei Yan, Hong-Fen Wu, et al.Frontiers in Oncology|May 16, 2022
Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized StudyXin Wang, Dong-Bing Zhao, Lin Yang, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 6, 2022
Influence of age on long-term net survival benefit for early-stage MALT lymphomas treated with radiotherapy: A SEER database analysis (2000-2015)Yunpeng Wu, Xin Liu, Brandon S Imber, et al.JCO Global Oncology|January 15, 2026
Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness AnalysisJing Yang, Qiu-Zi Zhong, Li-Ting Qian, et al.International Journal of Radiation Oncology, Biology, Physics|September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group DatabaseKe Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.Therapeutic Advances in Medical Oncology|October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphomaFei Luo, Qiu-Zi Zhong, Xin Liu, et al.Annals of Hematology|June 12, 2023
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG studyJia-Ying Li, Xiao-Rong Hou, Si-Ye Chen, et al.Advances in Radiation Oncology|April 17, 2025
Longitudinal Analyses and Predictive Factors of Radiation-Induced Lymphopenia After Postmastectomy Hypofractionated Radiation Therapy for Breast Cancer: A Pooled Cohort Study of 2 Prospective TrialsXu-Ran Zhao, Hui Fang, Hao Jing, et al.Med (New York, N.Y.)|August 22, 2025
Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II)Yuan Tang, Hao-Yue Li, Li-Chun Wei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2022
Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)Jing Jin, Yuan Tang, Chen Hu, et al.Pageof 30